Australia Flow Cytometry Market Size & Outlook, 2023-2030
Australia flow cytometry market, 2018-2030 (US$M)
Related Markets
Australia flow cytometry market highlights
- The Australia flow cytometry market generated a revenue of USD 57.7 million in 2023 and is expected to reach USD 87.5 million by 2030.
- The Australia market is expected to grow at a CAGR of 6.1% from 2024 to 2030.
- In terms of segment, instruments was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Flow cytometry market data book summary
| Market revenue in 2023 | USD 57.7 million |
| Market revenue in 2030 | USD 87.5 million |
| Growth rate | 6.1% (CAGR from 2023 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
| Key market players worldwide | Danaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp |
Other key industry trends
- In terms of revenue, Australia accounted for 1.3% of the global flow cytometry market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China flow cytometry market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 590.5 million by 2030.
Instruments was the largest segment with a revenue share of 36.22% in 2023. Horizon Databook has segmented the Australia flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
Excellent research facilities, world-class researchers, and a firm but flexible regulatory framework have made Australia a powerhouse of pharmaceutical and biotechnology innovation. According to the data published by the Australian Trade and Investment Commission, Australia has become hub to a thriving network of more than 470 biotechnology companies.
High presence of established pharmaceutical & biotechnology companies and extensive research and development initiatives being undertaken by them are expected to create high need for flow cytometry solutions & systems in the country. Furthermore, market players are increasingly adopting inorganic growth strategies to enter the lucrative Australian market, which is anticipated to support market growth in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Flow Cytometry Market Scope
Flow Cytometry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia flow cytometry market size, by product, 2018-2030 (US$M)
Australia Flow Cytometry Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
